Treatment Indications: correction of deep facial folds and severe volume loss; structural contouring of the cheekbones, jawline, and chin, restoration of facial architecture in cases of pronounced tissue atrophy
Release form: 1 × 1.0 mL pre-filled syringe
Compound: cross‑linked hyaluronic acid (HA) of non‑animal origin (HTL France raw material), manufactured with HBCT (Hexagonal Block Crosslinking Technology) for enhanced stability and longevity
Concentration of GC: 24 mg/mL
Lidocaine: 0.3%
Indications: high‑density volumizing and structural modeling; correction of deep depressions, cheekbone augmentation,, and jawline definition; cases requiring maximum support and long‑lasting
Order via WhatsApp
fillme-sale@ya.ru